Published in Laryngoscope on March 01, 1998
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46
Molecular predictors of clinical outcome in patients with head and neck squamous cell carcinoma. Int J Exp Pathol (2005) 1.18
Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. J Clin Pathol (1999) 1.08
High SEPT9_v1 Expression Is Associated with Poor Clinical Outcomes in Head and Neck Squamous Cell Carcinoma. Transl Oncol (2010) 0.92
DNA copy number variation and loss of heterozygosity in relation to recurrence of and survival from head and neck squamous cell carcinoma: a review. Head Neck (2008) 0.88
Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival. PLoS One (2015) 0.77
Recent advances in the molecular biology of head and neck tumours. Indian J Otolaryngol Head Neck Surg (1999) 0.75
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science (1991) 5.99
Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med (1994) 4.74
Fragile X genotype characterized by an unstable region of DNA. Science (1991) 4.33
Long-term follow-up results of a randomized drug abuse prevention trial in a white middle-class population. JAMA (1995) 3.98
Competency development in public health leadership. Am J Public Health (2000) 3.84
Preventing adolescent drug abuse through a multimodal cognitive-behavioral approach: results of a 3-year study. J Consult Clin Psychol (1990) 2.81
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell (1993) 2.73
Common chromosomal fragile site FRA16D sequence: identification of the FOR gene spanning FRA16D and homozygous deletions and translocation breakpoints in cancer cells. Hum Mol Genet (2000) 2.56
Physical activity and minority women: a qualitative study. Health Educ Behav (1998) 2.55
A refined physical map of the long arm of human chromosome 16. Genomics (1991) 2.15
Assignment of anonymous DNA probes to specific intervals of human chromosomes 16 and X. Hum Genet (1989) 2.10
Predicate-argument structure as a link between linguistic and nonlinguistic representations. Brain Lang (1990) 2.02
Surgical indications and timing of repair of traumatic ruptures of the thoracic aorta. Ann Thorac Surg (1998) 1.92
Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet (1992) 1.91
A new DNA marker tightly linked to the fragile X locus (FRAXA). Science (1989) 1.88
Heritable fragile sites on human chromosomes. V. A new class of fragile site requiring BrdU for expression. Am J Hum Genet (1980) 1.88
bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene (1996) 1.87
Fragile sites still breaking. Trends Genet (1998) 1.86
Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc Natl Acad Sci U S A (1999) 1.86
GeneKeyDB: a lightweight, gene-centric, relational database to support data mining environments. BMC Bioinformatics (2005) 1.83
Public health response for the 1996 Olympic Games. JAMA (1998) 1.80
Neurotoxicity of glucocorticoids in the primate brain. Horm Behav (1994) 1.79
Congenital malformations associated with a ring 4 chromosome. J Med Genet (1969) 1.73
A cognitive-behavioral approach to substance abuse prevention. Addict Behav (1984) 1.69
The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol (1994) 1.63
Extramural prevention research at the Centers for Disease Control and Prevention. Public Health Rep (2001) 1.61
Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol (1994) 1.59
Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell (1997) 1.55
Enhanced opioid efficacy in opioid dependence is caused by an altered signal transduction pathway. J Neurosci (1998) 1.54
A natural variant of the cysteine protease virulence factor of group A Streptococcus with an arginine-glycine-aspartic acid (RGD) motif preferentially binds human integrins alphavbeta3 and alphaIIbbeta3. Proc Natl Acad Sci U S A (1999) 1.53
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J (1994) 1.52
Evaluation of a primary care counselling service in Dorset. Br J Gen Pract (1998) 1.45
Superantigens - powerful modifiers of the immune system. Mol Med Today (2000) 1.43
The false consensus effect: predicting adolescents' tobacco use from normative expectations. Psychol Rep (1992) 1.43
Field cancerization in the aerodigestive tract--its etiology, manifestation, and significance. J Otolaryngol (1984) 1.43
Cloning, chromosomal mapping and characterization of the human metal-regulatory transcription factor MTF-1. Nucleic Acids Res (1994) 1.42
Validation of recombinant Sendai virus in a non-natural host model. Gene Ther (2010) 1.42
Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol Cell Biol (1995) 1.42
Medial paraspinal muscle electromyography: techniques of examination. Arch Phys Med Rehabil (1993) 1.40
Association of a chromosome deletion syndrome with a fragile site within the proto-oncogene CBL2. Nature (1995) 1.38
Opioid inhibition of rat periaqueductal grey neurones with identified projections to rostral ventromedial medulla in vitro. J Physiol (1996) 1.38
A cognitive-behavioral approach to substance abuse prevention: one-year follow-up. Addict Behav (1990) 1.38
Providing support to others and well-being in later life. J Gerontol (1992) 1.38
Reassessment of two apparent deletions of chromosome 16p to an ins(11;16) and a t(1;16) by chromosome painting. Ann Genet (1990) 1.34
The common fragile site in band q27 of the human X chromosome is not coincident with the fragile X. Clin Genet (1990) 1.33
The mouse CD69 gene. Structure, expression, and mapping to the NK gene complex. J Immunol (1994) 1.33
Characterisation of a new rare fragile site easily confused with the fragile X. Hum Mol Genet (1992) 1.31
A psychosocial approach to smoking prevention for urban black youth. Public Health Rep (1990) 1.31
Predictors of smoking prevalence among New York Latino youth. Am J Public Health (1992) 1.29
Excess thymidine induces folate sensitive fragile sites. Am J Med Genet (1985) 1.29
muO-conotoxin MrVIB selectively blocks Nav1.8 sensory neuron specific sodium channels and chronic pain behavior without motor deficits. Proc Natl Acad Sci U S A (2006) 1.26
Laser surgery in otolaryngology: interaction of CO2 laser and soft tissue. Ann N Y Acad Sci (1976) 1.26
Correlates and predictors of smoking among black adolescents. Addict Behav (1992) 1.25
The effects of scheduling format and booster sessions on a broad-spectrum psychosocial approach to smoking prevention. J Behav Med (1983) 1.23
Nociceptin receptor coupling to a potassium conductance in rat locus coeruleus neurones in vitro. Br J Pharmacol (1996) 1.23
Vocal cord nodules and polyps--the role of surgical treatment. Laryngoscope (1971) 1.21
FRA10B structure reveals common elements in repeat expansion and chromosomal fragile site genesis. Mol Cell (1998) 1.20
Isolation and characterization of rabbit serum and milk transferrins. Evidence for difference in sialic acid content only. Biochemistry (1968) 1.20
Predictive factors of success or failure in the endoscopic management of laryngeal and tracheal stenosis. Ann Otol Rhinol Laryngol (1982) 1.19
"External counterpressure" and "internal distention" for optimal laryngoscopic exposure of the anterior glottal commissure. Ann Otol Rhinol Laryngol (1994) 1.19
An expanded mouse-human hybrid cell panel for mapping human chromosome 16. Ann Genet (1990) 1.19
Persistence of physiological self antigen is required for the regulation of self tolerance. J Immunol (2000) 1.19
Erythroid 5-aminolevulinate synthase is located on the X chromosome. Am J Hum Genet (1990) 1.17
Outcome of staged reconstructive surgery for hypoplastic left heart syndrome following antenatal diagnosis. Arch Dis Child (2001) 1.17
Chromosomal fragile site FRA16D and DNA instability in cancer. Cancer Res (2000) 1.17
Interaction between phonological and semantic factors in auditory comprehension. Neuropsychologia (1981) 1.17
Smoking prevention among urban minority youth: assessing effects on outcome and mediating variables. Health Psychol (1992) 1.17
Cassini Imaging Science: initial results on Phoebe and Iapetus. Science (2005) 1.16
Recurrent respiratory papillomatosis: management with the CO2 laser. Ann Otol Rhinol Laryngol (1976) 1.16
Symptoms in early head and neck cancer: an inadequate indicator. Otolaryngol Head Neck Surg (1998) 1.15
Frequent deletions at Xq28 indicate genetic heterogeneity in Hunter syndrome. Hum Genet (1991) 1.15
Toluidine blue in the management of carcinoma of the oral cavity. Arch Otolaryngol (1968) 1.13
Cloning of the sulphamidase gene and identification of mutations in Sanfilippo A syndrome. Nat Genet (1995) 1.13
Carcinoma obstructing the trachea. Treatment by laser resection. N Engl J Med (1976) 1.12
The uptake of iron and transferrin by the human malignant melanoma cell. Biochim Biophys Acta (1990) 1.11
New classes of common fragile sites induced by 5-azacytidine and bromodeoxyuridine. Hum Genet (1985) 1.11
5-Aminolevulinate synthase is at 3p21 and thus not the primary defect in X-linked sideroblastic anemia. Am J Hum Genet (1988) 1.11
Cardiac complications of microsurgery of the larynx: etiology, incidence and prevention. Laryngoscope (1974) 1.10
The effect of the iron(III) chelator, desferrioxamine, on iron and transferrin uptake by the human malignant melanoma cell. Cancer Res (1994) 1.10
The human glycine receptor beta subunit: primary structure, functional characterisation and chromosomal localisation of the human and murine genes. Brain Res Mol Brain Res (1996) 1.07
Physical linkage of the fragile site FRA11B and a Jacobsen syndrome chromosome deletion breakpoint in 11q23.3. Hum Mol Genet (1994) 1.07
Quality of life as conveyed by pediatric patients with cancer. Qual Life Res (2004) 1.07
Genomic organization, exact localization, and tissue expression of the human CD26 (dipeptidyl peptidase IV) gene. Immunogenetics (1994) 1.06
Interleukin 4 is at 5q31 and interleukin 6 is at 7p15. Hum Genet (1988) 1.05
Chromosomal localization of the human alpha-L-iduronidase gene (IDUA) to 4p16.3. Am J Hum Genet (1990) 1.05
Oral stent as treatment adjunct for oral submucous fibrosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod (1996) 1.05
Normative expectations and the behavior of significant others: an integration of traditions in research on adolescents' cigarette smoking. Psychol Rep (1992) 1.04
The brn-2 gene regulates the melanocytic phenotype and tumorigenic potential of human melanoma cells. Oncogene (1995) 1.04
Impact of social influences and problem behavior on alcohol use among inner-city Hispanic and black adolescents. J Stud Alcohol (1999) 1.04
The kinetics of the interaction between rabbit transferrin and reticulocytes. Biochemistry (1969) 1.03
Gene structure and expression study of the SEDL gene for spondyloepiphyseal dysplasia tarda. Genomics (2000) 1.03
Regional mapping of the Batten disease locus (CLN3) to human chromosome 16p12. Am J Hum Genet (1991) 1.03
A skills training approach to smoking prevention among Hispanic youth. J Behav Med (1989) 1.02
The isochromosome 18p syndrome: confirmation of cytogenetic diagnosis in nine cases by in situ hybridization. Am J Hum Genet (1990) 1.01
Neuropsychological and neuroanatomical dimensions of ideomotor apraxia. Brain (1992) 1.01
High-prevalence Borrelia miyamotoi infection among [corrected] wild turkeys (Meleagris gallopavo) in Tennessee. J Med Entomol (2010) 1.00
Iron chelators of the pyridoxal isonicotinoyl hydrazone class. III. Formation constants with calcium(II), magnesium(II) and zinc(II). Biol Met (1989) 1.00
Base changes at position 792 of Escherichia coli 16S rRNA affect assembly of 70S ribosomes. Proc Natl Acad Sci U S A (1990) 1.00